Clinical Trial Update: Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating four chimera cytomegalovirus vaccines in healthy adult males aged 30-50 years; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Chimera CMV vaccines (Phase 1)

Snippet

Sponsor: CMV Research Foundation | Conditions: Cytomegalovirus | Phase 1 | Status: COMPLETED